SARMs
Cardarine (GW-501516)
Also called GW-501516 · GW · Endurobol
Cardarine attracts lifters who want cardio to feel easier, more work between rests or help during a cut. Others are interested in better cholesterol numbers. Those are different goals: human research supports changes in blood lipids, not proven endurance gains or protection from steroid-related heart risks. Cardarine is not a SARM, and animal cancer findings remain a serious concern.
Dosage & duration
Published lipid study · adults with low HDL
Different outcomes
Cardio, cholesterol and the cancer concern
-
Easier cardio
Some people report it, but an endurance benefit has not been established by the reviewed human research.
-
Better lipid results
The 12-week low-HDL trial measured blood lipids, not heart-attack prevention or safer steroid use.
-
Cancer concern
Animal findings prompted serious warnings; they do not yield a known human risk percentage.
Why people use Cardarine
The appeal is doing more work: easier cardio, repeated sets or longer rounds in a sport. Bodybuilders also discuss it during cuts, while some users are more interested in their cholesterol results than their performance. Cardarine acts on PPAR-delta, a regulator of metabolism; it is not an androgen-receptor drug like Ostarine or LGD.
Will cardio actually feel easier?
That is the recurring claim, but experiences differ. Some people report striking improvements; others notice little. One endurance-sport account reports better cholesterol without better endurance. Training changes, other drugs and unknown product contents make those accounts difficult to compare. They cannot predict a faster race or extra workout capacity for another person.
Better cholesterol does not mean protected heart health
A 12-week trial in people with low HDL cholesterol found improvements in several blood-lipid measures. It did not establish fewer heart attacks, safe steroid use or an endurance benefit. A better lab number should not be read as evidence that Cardarine cancels out another drug’s cardiovascular risks.
What about the cancer concern?
Animal toxicology findings led to serious safety warnings and development was abandoned. The human cancer risk cannot be calculated from personal accounts or by converting a rodent dose. There is no established safe recreational course. The published lipid-study amounts shown above describe research, not a recommended way to use it.
Model details: Cardarine (GW-501516) · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Stored 20 hnotverified; daily trial administration is not proof of 24 hhalf-life. The retained 20 h slower timescale is an assumption.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 20 hours
- Absorption half-life assumed
- 5 hours
- Reference amount for the relative scale
- 1 mg
- Absorption half-life is assumed to be one quarter of the slower timescale (5 h); it is not a measured absorption parameter.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- No sourced human Cmax, reference amplitude or half-life found in this pass.
- Exposure units must be relative; no inferred blood scale via other SARMs.
- Olson et al GW501516 lipidtrial
Clinical dose groups and lipid outcomes; no absolute concentration/timing calibration in the accessible abstract.
cardarine-relative-timing-2026-10 · version 1
Safety and interaction notes Read the limitations and discuss clinical questions with a professional
- Aromatizes
- No
Cardarine acts on PPAR-delta rather than the androgen receptor. The animal cancer concern is not resolved by short human lipid studies.
Common questions
Is Cardarine a SARM or a muscle-building drug?
It is a PPAR-delta agonist, not a SARM. Community interest is mainly endurance, cutting and cholesterol. Its human lipid trial does not establish muscle gain or bodybuilding effectiveness.
Will Cardarine fix cholesterol problems caused by steroids?
Human research found changes in lipid measurements in a specific low-HDL population. That does not prove it prevents cardiovascular harm from steroids or makes continued use safe.
Does a short course avoid the cancer concern?
No safe duration or dose has been established. Animal findings are a serious warning, while the risk for an individual human remains uncertain. A symptom-free experience report cannot answer a long-term cancer question.
Sources Labels, studies and notes behind this guide
Catalog evidence: Human clinical trials. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-10, 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Why people seek it
- Users describe easier cardio; that is not an established treatment benefit.
- What it is
- Cardarine and Andarine are different compounds despite similar names.
- Major uncertainty
- Animal-cancer findings cannot be dismissed or converted into a known human risk percentage.
- 1. Olson et al. — GW501516 lipid trial
Primary abstract via Europe PMC: 268 people with low HDL, 2.5/5/10 mg daily groups for 12 weeks; lipid endpoints, not athletic performance or long-term cancer safety.
- 2. USADA — GW1516
Official anti-doping source: PPAR-delta identity, unapproved/prohibited and animal-cancer concerns. Broad assertion of no human studies is not adopted; original lipid trial exists.
- 3. Olson et al GW501516 lipidtrial
Clinical dose groups and lipid outcomes; no absolute concentration/timing calibration in the accessible abstract.
Keep reading
Related compounds and examples
Related compounds
Ostarine (MK-2866 / Enobosarm)
Ostarine appeals to lifters who want to keep muscle while cutting or add modest size without injections. Reported experiences range from worthwhile strength and physique changes to disappointment. Its reputation as a mild SARM does not mean it avoids hormone, cholesterol or liver risks.
Ligandrol (LGD-4033)
Ligandrol attracts lifters looking for fuller muscles, size and strength without injections. The question that keeps coming up is how much of that fuller look remains after stopping. Human research found a lean-mass increase, alongside hormone and cholesterol changes; individual transformation reports cannot predict the result for another person.
Andarine (S4)
Andarine is sought for a harder, more defined look and strength during a cut, rather than dramatic weight gain. Users compare it with Anavar or Ostarine, but those comparisons are anecdotal. Yellow or green vision and difficulty seeing in low light are a distinctive concern in reports, not a harmless sign that the product is working.